(Q28246047)

https://api.crossref.org/works/10.1517/14740338.5.4.567

Acute silica toxicity: attenuation by amiodarone-induced pulmonary phospholipidosis

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14740338.5.4.567

Subchronic pulmonary inflammation and fibrosis induced by silica in rats are attenuated by amiodarone

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14740338.5.4.567

Identification of putative gene based markers of renal toxicity

20 April 2017

1 reference

https://api.crossref.org/works/10.1517/14740338.5.4.567

20 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Pulmonary changes induced by amphophilic drugs

20 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Drug-induced lipidosis and the alveolar macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Pulmonary and generalized lysosomal storage induced by amphiphilic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Cationic lipophilic drugs: mechanisms of action, potential consequences, and reversibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Cationic amphiphilic drug-induced phospholipidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Alveolar Proteinosis and Phospholipidoses of the Lungs*1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Antidepressant-induced lipidosis with special reference to tricyclic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Drug-induced phospholipidosis. II. Alterations in the phospholipid pattern of organs from mice, rats and guinea-pigs after chronic treatment with chlorphentermine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Amiodarone-induced pulmonary toxicity in rats: biochemical and pharmacological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Response of alveolar macrophages to amiodarone and desethylamiodarone, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Amiodarone-induced pulmonary inflammation. Correlation with drug dose and lung levels of drug, metabolite, and phospholipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Modifications of phospholipid metabolism induced by chlorpromazine, desmethylimipramine and propranolol in C6 glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Chlorphentermine-induced lipidosislike ultrastructural alterations in lungs and adrenal glands of several species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Amiodarone pneumonitis: three further cases with a review of published reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Amiodarone-induced phospholipidosis in rat alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Lipidosis induced by amphiphilic cationic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Transport of a fluorescent phosphatidylcholine analog from the plasma membrane to the Golgi apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Characterization of rapid membrane internalization and recycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Effects of amiodarone-induced phospholipidosis on pulmonary host defense functions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Biochemical and functional analysis of rat bronchoalveolar macrophages containing chemically induced phospholipid inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Lens opacities associated with lipidosis-like ultrastructural alterations in rats treated with chloroquine, chlorphentermine, or iprindole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Ocular side effects of amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Effects of long-term chloroquine exposure on the phospholipid metabolism in retina and pigment epithelium of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Aminoglycoside-induced renal phospholipidosis and nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Ultrastructural studies of the hepatic changes brought about by Clindamycin and Erythromycin in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

In vitro and in vivo ultrastructural changes induced by macrolide antibiotic LY281389.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Histopathologic analysis of suspected amiodarone hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Drug-induced steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Chlorphentermine-induced abnormal cytoplasmic inclusions in peripheral blood cells of rats and guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

A clinical flow cytometric biomarker strategy: validation of peripheral leukocyte phospholipidosis using Nile red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Effect of Chloroquine on Morphology of Cytoplasmic Granules in Maturing Human Leukocytes—an Ultrastructural Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Effect of amiodarone on the phospholipid and lamellar body content of lymphoblasts in vitro and peripheral blood lymphocytes in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Nile red staining of lysosomal phospholipid inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Reaction mechanism of the Ca2 plus-dependent ATPase of sarcoplasmic reticulum from skeletal muscle. IV. Hydroxamate formation from a phosphorylated intermediate and 2-hydroxy-5-nitrobenzyl hydroxylamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

In vivo toxicity screening programs using metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

An aminomethylpyrimidine DPP-IV inhibitor with improved properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Validation of an in vitro screen for phospholipidosis using a high-content biology platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Establishment of an in vitro high-throughput screening assay for detecting phospholipidosis-inducing potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Tricyclic antidepressant-induced lipidosis in human peripheral monocytes in vitro, as well as in a monocyte-derived cell line, as monitored by spectrofluorimetry and flow cytometry after staining with Nile red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Advances in toxicogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

The role of transcriptome analysis in pre-clinical toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Natural history of Type A Niemann-Pick disease: possible endpoints for therapeutic trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Effects of lysophosphatidylcholine on monolayer cell permeability of human coronary artery endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

Detection ofin vivo biomarkers of phospholipidosis using NMR-based metabonomic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567

A metabonomic approach to the investigation of drug-induced phospholipidosis: an NMR spectroscopy and pattern recognition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.5.4.567